Cyclic acid anhydrides as a new class of potent, selective and non-peptidic inhibitors of geranylgeranyl transferase
- 26 November 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (2) , 255-259
- https://doi.org/10.1016/s0960-894x(01)00718-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoBMolecular and Cellular Biology, 1999
- Non-Ras targets of farnesyltransferase inhibitors: focus on RhoOncogene, 1998
- Ras Farnesyltransferase: A New Therapeutic TargetJournal of Medicinal Chemistry, 1997
- Inhibition of ras prenylation: A novel approach to cancer chemotherapyPharmacology & Therapeutics, 1997
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996
- Activation of Rac1, RhoA, and Mitogen-Activated Protein Kinases Is Required for Ras TransformationMolecular and Cellular Biology, 1995
- Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.Molecular and Cellular Biology, 1994
- Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity.Proceedings of the National Academy of Sciences, 1992
- Ras C-terminal processing enzymes—New drug targets?Cell, 1991
- ras GENESAnnual Review of Biochemistry, 1987